住院与非住院COVID患者淋巴系统改变及小血管病存在情况:PSMD指数与DTI-ALPS研究
本研究基于「neuroCOVID MRI dWI and fMRI with reversal learning」数据集88名19-65岁参与者,比较72例COVID-19阳性患者(30例住院、42例非住院)与16例阴性对照的PSMD指数和DTI-ALPS参数。住院COVID患者PSMD指数较对照显著升高提示小血管病,非住院患者与对照无显著差异;各组间DTI-ALPS值均无显著差异,神经认知测试评分与PSMD或DTI-ALPS值无显著相关。
要点
- 住院COVID患者PSMD指数较对照显著升高,提示存在小血管病。
- 非住院COVID患者PSMD值与对照无显著差异。
- 各组间DTI-ALPS值均无显著差异。
核心结论
- 需住院的重症COVID-19与PSMD指数值升高相关,提示即使无显性神经系统症状也存在小血管病;门诊管理的轻症COVID-19未表现出显著小血管病或淋巴系统功能障碍。
研究设计与样本
- 研究数据来自「neuroCOVID MRI dWI and fMRI with reversal learning」数据集,共88名19-65岁参与者,包括72例COVID-19阳性患者(30例住院、42例非住院)和16例COVID-19阴性对照。
诊断标准与关键数值
- PSMD为骨架化平均弥散率峰值宽度,是检测小血管病的敏感生物标志物。
- DTI-ALPS为沿血管周围间隙的弥散张量图像分析,用于测量淋巴系统功能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: It is known that COVID-19 causes brain damage in the acute phase and leads to neurological complications such as dementia and brain fog in the chronic phase. Many factors have been implicated in these complications, including glymphatic system disorders, small vessel disease, and widespread inflammation. Peak width of skeletonized mean diffusivity (PSMD) is a sensitive biomarker for SVD, while the diffusion tensor image analysis along the perivascular space (DTI-ALPS) measures glymphatic system function. This study aims to investigate changes in PSMD and DTI-ALPS parameters in COVID-19 patients.
METHODS: Clinical and MRI data were obtained from the "neuroCOVID MRI dWI and fMRI with reversal learning" dataset, comprising 88 participants aged 19-65 years. Participants included 72 COVID-19-positive patients (30 hospitalized and 42 non-hospitalized) and 16 COVID-19-negative controls. None had neurological symptoms aside from anosmia. Neuropsychiatric symptoms were assessed using validated scales: depressive symptoms with the Patient Health Questionnaire-9 (PHQ-9) and anxiety symptoms with the Generalized Anxiety Disorder 7-item scale (GAD-7). Cognitive functioning was evaluated using the Addenbrooke's Cognitive Examination (ACE-III), while executive functioning was measured with the Ineco Frontal Screening (IFS-Ch). Functional capacity was assessed using the Six Minute Walk Test (6MWT). MRI scans were processed to calculate PSMD and DTI-ALPS values. Statistical analyses compared hospitalized and non-hospitalized COVID-19 patients with controls using the Mann-Whitney U test and partial correlation analysis.
RESULTS: Hospitalized COVID-19 patients showed a significant increase in PSMD index values compared to controls indicating SVD. Non-hospitalized COVID-19 patients did not differ significantly from controls in PSMD values. No significant differences were found in DTI-ALPS values between any COVID-19 groups and controls. Additionally, there were no significant correlations between neurocognitive test scores and PSMD or DTI-ALPS values.
CONCLUSION: Severe COVID-19 cases requiring hospitalization are associated with increased PSMD index values, suggesting the presence of small vessel disease even in the absence of overt neurological symptoms. Mild COVID-19 cases managed outpatiently do not exhibit significant SVD or glymphatic dysfunction.
引用
- Genç B, Buruk MS, Özçağlayan A, et al. Alterations in the Glymphatic System and Presence of Small Vessel Disease in Hospitalized and Non-hospitalized COVID Patients: A Study of PSMD Index and DTI-ALPS. Acad Radiol. 2025. PMID: 40057390. doi:10.1016/j.acra.2025.02.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。